España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Scott Krasik
Stitch Fix's 'Unique' Business Model Isn't Enough To Make Buckingham A Bull
Finish Line Shares Receive A Boost After Buckingham Upgrade
Why Fossil's Huge Move Might Not Last Too Long
Finish Line Shares Receive A Boost After Buckingham Upgrade
Why Fossil's Huge Move Might Not Last Too Long
Analyst: Nike's Recovery Will Take Longer Than Expected
Buckingham: Finish Line's Q3 Could Be 'Positive Read-Through' For Foot Locker
Analyst: Nike's Recovery Will Take Longer Than Expected
Buckingham: Finish Line's Q3 Could Be 'Positive Read-Through' For Foot Locker
Analyst Raises Nike Price Target Ahead Of Q2 Print
If The Shoe Fits: Analyst Upgrades Steve Madden
Read More...
Scott Krasik Recent News
EA Removes Microtransactions From 'Star Wars Battlefront II' Following User Backlash
Michael Kors Scores With Strong Q2, But What's The Deal With That Guidance?
4 Views On How To Play Activision Blizzard Post-Earnings
Under Armour's Weak Q3 Leaves Investors With 3 Concerns
Foot Locker Catalysts Are Few And Far Between
Analysts Say This Could Be A Potential Game Changer For Nike
Nike Sell-Side Roundup: Staying Bullish Is The Right Foot Forward
Analyst Sizes Up Nike, Finds A Buy Rating Still Fits
Making Gains In Video Games: Analyst Gets Bullish On Activision, EA And Take Two
Finish Line's Shin Splints: Poor Quarterly Pre-Announcement Pummels Stock, Downgrade Follows
An Analyst's First Impression Of DSW's Big Q2 Beat
Was The Foot Locker Sell-Off Overdone?
Sell-Side Sees Opportunity To Bag Shares Of Coach On Post-Earnings Pullback
2 Things We Learned About Michael Kors
4 Reasons Sell-Side Is Questioning Under Armour's Long-Term Story
3 Reasons Investors Should Stay Cautious On Under Armour
Skechers Shares Have Potential For 20% Upside From Here
Coach At 52-Week Highs Following Analyst Upgrade
Skechers' New Product Cycle Earns An Upgrade
This Analyst Still Sees 27% Upside Potential In Under Armour
4 Reasons Finish Line Shares Could Remain Range-Bound In The Near Term
4 Reasons To Add Positions Of DSW Shares
Under Armour Shares Higher As Buckingham Upgrades To Buy